Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges. (Q48290538)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28948324 AND SRC:MED&resulttype=core&format=json

31 March 2020

title

Clinical evaluation of macrophages in cancer: role in treatment, modulation and challenges (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28948324 AND SRC:MED&resulttype=core&format=json

31 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28948324 AND SRC:MED&resulttype=core&format=json

31 March 2020

Patrick F Forde

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28948324 AND SRC:MED&resulttype=core&format=json

31 March 2020

author name string

Declan M Soden

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28948324 AND SRC:MED&resulttype=core&format=json

31 March 2020

publication date

25 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28948324 AND SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

31 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28948324 AND SRC:MED&resulttype=core&format=json

31 March 2020

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28948324 AND SRC:MED&resulttype=core&format=json

31 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28948324 AND SRC:MED&resulttype=core&format=json

31 March 2020

page(s)

1509-1527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28948324 AND SRC:MED&resulttype=core&format=json

The era of bioengineering: how will this affect the next generation of cancer immunotherapy?

31 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Cancer and innate immune system interactions: translational potentials for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Exploring the full spectrum of macrophage activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Macrophage activation and polarization: nomenclature and experimental guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

M1 and M2 macrophages: the chicken and the egg of immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Depletion of cutaneous macrophages and dendritic cells promotes growth of basal cell carcinoma in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Role of macrophages in malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Macrophage diversity enhances tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The interaction of anticancer therapies with tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumor-associated macrophages: from mechanisms to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Macrophages predict treatment outcome in Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumor infiltration by FcγRIII (CD16) myeloid cells is associated with improved survival in patients with colorectal carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

High macrophage infiltration along the tumor front correlates with improved survival in colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Prognostic value of tumor-associated macrophages according to histologic locations and hormone receptor status in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Opposite Effects of M1 and M2 Macrophage Subtypes on Lung Cancer Progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Prognostic impact of tumor-associated macrophage infiltration in non-small cell lung cancer: A systemic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumor-associated macrophages contribute to tumor progression in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Colony-stimulating factor-1 antibody reverses chemoresistance in human MCF-7 breast cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

High infiltration of tumor-associated macrophages is associated with a poor response to chemotherapy and poor prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumor-associated macrophages in human breast cancer parenchyma negatively correlate with lymphatic metastasis after neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The tumour stromal features are associated with resistance to 5-FU-based chemoradiotherapy and a poor prognosis in patients with oral squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Macrophage IL-10 blocks CD8 T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Macrophages and therapeutic resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Macrophage regulation of tumor responses to anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The effect of radiation on the immune response to cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Expression of NF-κB p50 in tumor stroma limits the control of tumors by radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Inhibiting vasculogenesis after radiation: a new paradigm to improve local control by radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Radiation therapy-induced tumor invasiveness is associated with SDF-1-regulated macrophage mobilization and vasculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

M2-polarized macrophages contribute to neovasculogenesis, leading to relapse of oral cancer following radiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

TH2-Polarized CD4( ) T Cells and Macrophages Limit Efficacy of Radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Ionizing radiation modulates human macrophages towards a pro-inflammatory phenotype preserving their pro-invasive and pro-angiogenic capacities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Can macrophages within the microenvironment of locally invasive rectal cancers predict response to radiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

21 January 2018

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

PD-1 signaling in primary T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Combination strategies to enhance antitumor ADCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Antibody therapeutics in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

PD-1 blockade induces responses by inhibiting adaptive immune resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Granulocyte colony-stimulating factor and differentiation-induction in myeloid leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c( )MHCII( ) Macrophages and Dendritic Cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Priming the pancreatic cancer tumor microenvironment for checkpoint-inhibitor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Does vaccine-primed pancreatic cancer offer better candidates for immune-based therapies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Constitutive production of multiple colony-stimulating factors in patients with lung cancer associated with neutrophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Autocrine CCL2 promotes cell migration and invasion via PKC activation and tyrosine phosphorylation of paxillin in bladder cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumor-associated fibroblasts recruit blood monocytes into tumor tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

CCL2 and interleukin-6 promote survival of human CD11b peripheral blood mononuclear cells and induce M2-type macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Monocyte chemoattractant protein-1/CC chemokine ligand 2 enhances apoptotic cell removal by macrophages through Rac1 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Chemokine (C-C motif) ligand 2 engages CCR2 stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Chemotherapy Induces Macrophage Chemoattractant Protein-1 Production in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumor-Derived CCL2 Mediates Resistance to Radiotherapy in Pancreatic Ductal Adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Prioritizing genes associated with prostate cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Profile of monocyte chemoattractant protein-1 circulating levels in gastric cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Expression of monocyte chemotactic protein-1/CCL2 in gastric cancer and its relationship with tumor hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and -independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

CCL2 Promotes Colorectal Carcinogenesis by Enhancing Polymorphonuclear Myeloid-Derived Suppressor Cell Population and Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

CCL2 expression correlates with Snail expression and affects the prognosis of patients with gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Phase 2 study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 (CCL2), in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Targeting the CCL2-CCR2 signaling axis in cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Exclusion of T Cells From Pancreatic Carcinomas in Mice Is Regulated by Ly6C(low) F4/80( ) Extratumoral Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Novel CSF1-S100A10 fusion gene and CSF1 transcript identified by RNA sequencing in tenosynovial giant cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Trabectedin: A drug from the sea that strikes tumor-associated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Antitumor and anti-inflammatory effects of trabectedin on human myxoid liposarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Combined Trabectedin and anti-PD1 antibody produces a synergistic antitumor effect in a murine model of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Immune-mediated adverse events associated with ipilimumab ctla-4 blockade therapy: the underlying mechanisms and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

A Breakthrough: Macrophage-Directed Cancer Immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Immunostimulatory early phenotype of tumor-associated macrophages does not predict tumor growth outcome in an HLA-DR mouse model of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Resistant mechanisms to BRAF inhibitors in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Co-inhibition of colony stimulating factor-1 receptor and BRAF oncogene in mouse models of BRAFV600E melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The macrophage colony-stimulating factor 1 response signature in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Prognostic significance of tumor-associated macrophages in solid tumor: a meta-analysis of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

High density of CD204-positive macrophages predicts worse clinical prognosis in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The absence of CCL2 expression in cervical carcinoma is associated with increased survival and loss of heterozygosity at 17q11.2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Detection of M2-macrophages in uveal melanoma and relation with survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Prognostic significance of serum soluble CD163 level in patients with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

The strange case of TGN1412

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Role of Macrophage Targeting in the Antitumor Activity of Trabectedin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00262-017-2065-0

10.1007/S00262-017-2065-0

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28948324 AND SRC:MED&resulttype=core&format=json

31 March 2020

1 reference